TEL HASHOMER MEDICAL RESEARCH INFRASTRUCTURE AND SERVICES LTD.
发明人:
申请号:
EP14865441.1
公开号:
EP3074391A4
申请日:
2014.11.27
申请国别(地区):
EP
年份:
2017
代理人:
摘要:
Provided are novel compounds which are capable of inhibiting an activity of RNA polymerase I, and uses thereof in treating diseases or disorders modulated by RNA polymerase I, preferably autoimmune diseases such as multiple sclerosis and proliferative diseases.